New medicine reduced risk for heart failure emergencies, hospital visits
Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today ...
Nov 13, 2020
0
3